Systemic Sclerosis

Mycophenolic Acid Treatment Not Associated with More Severe COVID-19 Infection

September 28, 2022

Throughout the pandemic, rheumatologists have been concerned that their patients may be at risk of developing more severe forms of the COVID-19 disease as a result of their rheumatic disease or treatment.

Higher Mortality Rates in Patients With Systemic Sclerosis-Associated Pulmonary Hypertension

May 05, 2022

According to investigators, pulmonary hypertension indicates an increased risk of mortality in patients with systemic sclerosis.

Systemic Sclerosis Increases Risk of Adverse Pregnancy Outcomes

April 28, 2022

“In recent years, the habit of delaying pregnancy because of social and economic reasons has become more common, increasing the possibility of getting pregnant after the onset of the disease," investigators stated. "This fact makes pregnancy a more frequent issue to deal with in the present years.”

Worse COVID-19 Outcomes Seen in Patients With Systemic Sclerosis

March 23, 2022

A retrospective study analyzed patients with systemic sclerosis to determine prevalence, severity, and mortality within this patient population.

Robert F. Spiera, MD: Mycophenolate Treatment Is Associated with Improved Outcomes in Trial of Lenabasum in Patients With Systemic Sclerosis

November 22, 2021

Robert F Spiera, MD, explains background mycophenolate treatment and its associated improved outcomes in patients with systemic sclerosis receiving lenabasum.

SPIN-CHAT Program Reduces Anxiety and Depression Symptoms for Patients With Rheumatic Disease

April 30, 2021

The SPIN-CHAT Program was developed by investigators in order to help participants deal with isolation and learn better mental health coping mechanisms.

Tocilizumab Approved by the FDA for Systemic Sclerosis-Associated Interstitial Lung Disease

March 09, 2021

Subcutaneous injection of tocilizumab has been shown to improve the rate of lung function in patients with systemic sclerosis-induced interstitial lung disease when compared with a placebo.

Stem Cell Treatment Improves Quality of Life in Systemic Sclerosis

September 28, 2020

Autologous hematopoietic stem cell transplants (AHSCT) improve the quality of life in patients with systemic sclerosis (SSc), researchers say.

Ninfetanib Improves and Stabilizes Lung Function in Systemic Sclerosis

November 18, 2019

Patients who have systemic sclerosis-associated interstitial lung disease and received nintedanib were more likely to have improved lung function than patients who received a placebo, according to a new study. Not only did nintedanib improve forced vital capacity, but patients who received the drug were less likely to experience declining clinical status and more likely to see their conditions stabilize.

Riociguat for Systemic Sclerosis Digital Ulcers May Require Longer Treatment

September 12, 2019

A proof of concept clinical trial for riociguat (Adempas, Bayer) for patients with systemic sclerosis indicates that longer treatment periods may be necessary to heal digital ulcers. In this trial, the treatment wasn't effective in reducing the number of digital ulcers.